Position in ABBV
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$8,838,351
+$1,206,627 QoQ
Shares Held
35,123
+0.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
2.65%
of 13F equity value
Holder Rank
#986
of 4,153 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Herold Advisors, Inc. holds $36,055,157 across 9 Drug Manufacturers - General names. ABBV ranks #2 (24.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,550 | $12,653,987 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
35,123 | $8,838,351 | |
| 3 | MRK |
Merck & Co., Inc.
|
31,620 | $4,063,170 | |
| 4 | JNJ |
Johnson & Johnson
|
15,267 | $3,877,359 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
35,910 | $2,069,134 | |
| 6 | PFE |
Pfizer Inc
|
81,250 | $1,956,500 | |
| 7 | AMGN |
Amgen Inc
|
3,526 | $1,276,835 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,624 | $836,876 |
All Filings in ABBV
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,838,351 | 35,123 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $7,631,724 | 35,090 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $8,017,714 | 35,090 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,300,014 | 35,847 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $6,341,521 | 34,164 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $7,535,596 | 35,966 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $6,706,753 | 37,742 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,651,165 | 38,744 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,714,836 | 39,149 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $6,982,624 | 38,345 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $6,009,426 | 38,778 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $5,678,589 | 38,096 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $4,786,687 | 35,528 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $5,413,798 | 33,970 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $5,483,750 | 33,932 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,348,135 | 32,398 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $4,917,814 | 32,109 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $5,162,392 | 31,845 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $4,152,988 | 30,672 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $3,323,798 | 30,813 | Shares | Sole | 2021-11-03 | |
| No filing history on record for this holder in this stock. | ||||||